High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan

被引:104
作者
Wu, MJ
Lian, JD
Yang, CR
Cheng, CH
Chen, CH
Lee, WC
Shu, KH
Tang, MJ
机构
[1] Taichung Vet Gen Hosp, Div Nephrol, Taichung 407, Taiwan
[2] Taichung Vet Gen Hosp, Div Urol, Taichung 407, Taiwan
[3] Natl Yang Ming Univ, Inst Clin Med, Taichung, Taiwan
[4] Chung Shan Med Univ, Div Nephrol, Taichung, Taiwan
[5] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan
关键词
transitional cell carcinoma (TCC); kidney transplantation; malignancy;
D O I
10.1053/j.ajkd.2004.03.016
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Cancer is a well-documented complication after kidney transplantation. Increased incidence of bladder cancer had been reported in long-term hemodialysis patients in Taiwan. Herein, the authors report a very high cumulative incidence of transitional cell carcinoma (TCC) of the urinary tract after kidney transplantation in Taiwan. Methods: The authors retrospectively reviewed the clinical data, medical records, and outcome of 730 kidney transplant (KT) recipients. The cumulative incidence of TCC was computed. The Cox regression method was used to analysis the role of potential risk factors. Results: After a mean follow-up duration of 72.2+/-54.4 months, 69 cancers were diagnosed in 63 (8.6%) KT recipients. Of them, 30 cases (4.1%) were TCC. The cumulative incidence for TCC was 3.0% after 3 years of graft survival, increasing to 7.2% at 6 years and 17.5% at 10 years. Compared with the general population in Taiwan, the standardized mortality ratio was 398.4 (male, 192.6; female, 875.6). Painless gross hematuria was the cardinal initial symptom in 22 (73.3%) of the 30 KT recipients with TCC. Another 4 (13.3%) KT recipients with TCC presented with chronic. urinary tract infection (UTI). Bilateral nephroureterectomy with removal of bladder cuffs was performed in 18 (60%) patients. Synchronous TCC in bilateral upper urinary tracts was confirmed in 11 (36.7%) of KT recipients with TCC. The age at the time of KT, female sex, compound analgesics usage, Chinese herb usage, and underground water intake had statistical significance as risk factors (P<0.05). Conclusions: The KT recipients are at extremely high risk for TCC in Taiwan, with an incidence of 4.1%. This study indicates that hematuria and chronic UTI are the initial presentation of TCC in KT recipients. Carefully urologic screening is indicated for patients with high risk for TCC, including those with older age, compound analgesics usage, Chinese herbs usage, and underground water intake as well as women.
引用
收藏
页码:1091 / 1097
页数:7
相关论文
共 29 条
[11]  
HAUSER AC, 1990, LANCET, V1, P335
[12]   Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients [J].
Herman, M ;
Weinstein, T ;
Korzets, A ;
Chagnac, A ;
Ori, Y ;
Zevin, D ;
Malachi, T ;
Gafter, U .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2001, 137 (01) :14-20
[13]  
Hsieh YF, 1979, J FORMOS MED ASSOC, V78, P749
[14]  
Kälble T, 2001, UROLOGE A, V40, P447, DOI 10.1007/s001200170003
[15]   High mortality from urothelial carcinoma despite regular tumor screening in patients with analgesic nephropathy after renal transplantation [J].
Kliem, V ;
Thom, W ;
Thon, W ;
Krautzig, S ;
Kolditz, M ;
Behrend, M ;
Pichlmayr, R ;
Koch, KM ;
Frei, U ;
Brunkhorst, R .
TRANSPLANT INTERNATIONAL, 1996, 9 (03) :231-235
[16]  
MCCREDIE M, 1982, CANCER, V49, P2617, DOI 10.1002/1097-0142(19820615)49:12<2617::AID-CNCR2820491235>3.0.CO
[17]  
2-X
[18]   Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). [J].
Nortier, JL ;
Martinez, MM ;
Schmeiser, HH ;
Arlt, VM ;
Bieler, CA ;
Petein, M ;
Depierreux, MF ;
De Pauw, L ;
Abramowicz, D ;
Vereerstraeten, P ;
Vanherweghem, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (23) :1686-1692
[19]   Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) [J].
Nortier, JL ;
Vanherweghem, JL .
TOXICOLOGY, 2002, 181 :577-580
[20]   Transitional cell carcinoma in dialysis patients [J].
Ou, JH ;
Pan, CC ;
Lin, JSN ;
Tzai, TS ;
Yang, WH ;
Chang, CC ;
Cheng, HL ;
Lin, YM ;
Tong, YC .
EUROPEAN UROLOGY, 2000, 37 (01) :90-94